The Effectiveness of Ologen® Collagen Matrix in Preventing Intraocular Pressure (IOP) Spikes After Ahmed Glaucoma Valve Surgery (AGV-FP7)

Stopped early · Phase 2

Conditions studied: Glaucoma

In brief

The purpose of this study is to investigate whether placing Ologen over the posterior plate of the Ahmed glaucoma drainage device during initial implantation will allow the formation of a thinner capsule, and decrease the incidence and/or the extent of IOP elevation during the postoperative period.

Key facts

Study ID

NCT02990143

Run by

The New York Eye & Ear Infirmary

People needed

30

Starts

2014-01-15

Expected to finish

2017-12-15

Last updated by the study team

2021-03-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥18 years.
• Uncontrolled treated glaucoma requiring AGV-FP7 surgery.
• Subject must be able and willing to cooperate with investigation plan.
• Subject must be able and willing to complete postoperative follow-up requirements
• Subject must be willing to sign informed consent form

You may not qualify if…

• Known allergic reaction to porcine collagen
• History of uveitis
• Corneal opacity or irregularity, preventing visualization of patency of tip of tube or accurate applanation
• History of scleral buckle

Where it is running

• New York Eye and Ear Infirmary — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.